DAY ONE WEDNESDAY, APRIL 1, 2020
7:30
Registration and Continental Breakfast
Pricing Pressures, Policy Updates and Formulary Trends
8:30
Chairman’s Welcome and Opening Remarks
Chris Dowd
Executive Vice President, Market and Product Development
ConnectiveRx
8:45
STATE OF THE INDUSTRY
Navigate Evolving Healthcare Regulations and Proposals Amidst a
Shifting Landscape
Alyssa Palisi
Professional Staff Member
House Committee on Ways and Means (Invited)
9:30
PARTNERSHIP PAVILION
Navigating the Future of Pharma, PBM and Payer Relationships
MODERATOR:
Chris Dowd
Executive Vice President, Market and Product Development
ConnectiveRx
CONVERSATION CONTRIBUTORS:
George Keefe
Vice President and Head, Market Access
Teva Pharmaceuticals
Michael DiFiore
Head, Market Access
Sunovion Pharmaceuticals
10:30
Networking and Refreshment Break
11:00
PBM Insights — Advancements in Formulary Design and Management
Speaker TBA
12:00
Networking Luncheon
1:15
Employer Perspective Fireside Chat
Lauren Vela, MBA
Senior Director, Member Value
Pacific Business Group on Health
2:15
Assess the Landscape for Prior Authorization and Reimbursement Support — Reexamining the Roles of the Manufacturer and the Pharmacy
David Kowalsky
Director, Market Access and Patient Services
EyePoint Pharmaceuticals
3:30
CHOOSE BETWEEN TWO CONCURRENT WORKSHOPS (A-B)
A Keeping Up with Copay Industry Trends — What’s What and How Does It All Work
This session provides resources and foundational knowledge on copay program principles and strategies, as well as current industry trends and challenges on the horizon.
Clay Tucker
Vice President, New Business Development — Western US
ConnectiveRx
B Access and Reimbursement Executive Exchange*
During this advanced session, benchmark with key industry directors and executives on challenges facing the industry amid shifting market dynamics. Driven by attendees, take time to collaborate with industry counterparts, ensure operational alignments and brainstorm strategic solutions to key initiatives that are impacting the future of access and reimbursement.
Chris Dowd
Executive Vice President,
Market and Product Development
ConnectiveRx
*CBI reserves the right to qualify participants for this session. Participants must be Director level or above and currently be employed by a life sciences manufacturer.
5:00
Close of Day One
COCKTAIL RECEPTION immediately following the final session Hosted by: 
DAY TWO THURSDAY, APRIL 2, 2020
8:00
Breakfast Hosted by: 
8:30
Chairperson’s Review of Day One
Chris Dowd
Executive Vice President, Market and Product Development
ConnectiveRx
Copay, Coupons and Accumulators
8:45
PATIENT SPOTLIGHT
An Inside Look at the Patient Experience and Real-World Access Challenges
Jenn McNary
Advocacy and Outreach Director
Beauhawks
9:30
Specialty Spotlight — Overcome Formulary, Coupon, Copay and Access Challenges
Ticia Cawley
Vice President, Specialty Programs
ConnectiveRx
Katrina Cooper, PharmD
Clinical Specialty Pharmacist
Vanderbilt Medical Center
10:30
Networking and Refreshment Break Hosted by: 
11:00
Affordability First — Leverage Digital Engagements to Drive Affordability
Bob Raffo
President & CEO
FirstView
12:00
Networking Luncheon
1:15
CHOOSE FROM THREE TAILORED TRACKS (1-3)
TRACK 1 Access and Affordability
I. Look Beyond Free Drug Programs — Patient Support Models
II. Implement Performance Measurements to Justify the Cost of Copay Programs
TRACK LEADERS:
Brent Schwartz
Executive Director, Reimbursement – U.S. Eye Care
Allergan
Gerard Rivera, PharmD
CEO
Rx Experts (Subsidiary of Pacific Pharmacy Group)
TRACK 2 Rebates and Contracting
I. Explore Point-of-Sale Rebates and Discounts
II. Explore Innovative Pricing and Contracting Models —
Outcomes- Based Contracting, Long-Term Plans and Value-Based Pricing
TRACK LEADER:
Kim Gwiazdzinski
former Assistant Vice President Trade Relations, Value and Outcomes Contracting
Prime Therapeutics
TRACK 3 Strategic Launch Planning
I. Brand Strategy Guide for Pre-Commercialization Planning and Understand Market Access Impact to Propel Launch
II. Marketing in the 21st Century
TRACK LEADER:
Donna Situ
Executive Director
Portola Pharmaceuticals
3:30
Networking and Refreshment Break
4:00
Copay Accumulator Programs Intensive
As the adoption of copay accumulators and maximizers expand, so does the need for pharmaceutical manufacturers to ensure a comprehensive understanding of the impact to the commercially insured patient population. In this interactive intensive, unravel program complexities and navigate the impact of this cost-shifting benefit design.
Kevin O’Meara
Subject Matter Expert, Affordability & Accumulator Strategies
ConnectiveRx
5:00
Close of Day Two
Networking, Wine and Cheese Reception immediately following the final session on day two
DAY THREE FRIDAY, APRIL 23, 2020
8:00
Continental Breakfast
8:00
Chairman’s Review of Day Two
Chris Dowd
Executive Vice President, Market and Product Development
ConnectiveRx
Innovation and Digital Disruptions
8:45
Identify Disruptions in Market Access —
Major Market Mergers, Joint Ventures and Emerging Digital Innovators
Michael DiFiore
Head, Market Access
Sunovion Pharmaceuticals
9:30
Car-T/Cell and Gene Therapy Formulary Design —
How to Find Value and Pay for Curative Therapies
Lauren Sullivan
Member
Epstein Becker Green
10:15
Networking and Refreshment Break
10:45
TECH TALK
Leverage Digital Therapeutics and Mobile Health to Drive Efficiencies in the HealthCare Ecosystem
Andy Molnar
Senior Director, Market Access
Cognoa
12:00
Close of Conference
DAY ONE WEDNESDAY, APRIL 1, 2020
7:30
Registration and Continental Breakfast
Pricing Pressures, Policy Updates and Formulary Trends
8:30
Chairman’s Welcome and Opening Remarks
Chris Dowd
Executive Vice President, Market and Product Development
ConnectiveRx
8:45
STATE OF THE INDUSTRY
Navigate Evolving Healthcare Regulations and Proposals Amidst a
Shifting Landscape
Alyssa Palisi
Professional Staff Member
House Committee on Ways and Means (Invited)
9:30
PARTNERSHIP PAVILION
Navigating the Future of Pharma, PBM and Payer Relationships
MODERATOR:
Chris Dowd
Executive Vice President, Market and Product Development
ConnectiveRx
CONVERSATION CONTRIBUTORS:
George Keefe
Vice President and Head, Market Access
Teva Pharmaceuticals
Michael DiFiore
Head, Market Access
Sunovion Pharmaceuticals
10:30
Networking and Refreshment Break
11:00
PBM Insights — Advancements in Formulary Design and Management
Speaker TBA
12:00
Networking Luncheon
1:15
Employer Perspective Fireside Chat
Lauren Vela, MBA
Senior Director, Member Value
Pacific Business Group on Health
2:15
Assess the Landscape for Prior Authorization and Reimbursement Support — Reexamining the Roles of the Manufacturer and the Pharmacy
David Kowalsky
Director, Market Access and Patient Services
EyePoint Pharmaceuticals
3:30
CHOOSE BETWEEN TWO CONCURRENT WORKSHOPS (A-B)
A Keeping Up with Copay Industry Trends — What’s What and How Does It All Work
This session provides resources and foundational knowledge on copay program principles and strategies, as well as current industry trends and challenges on the horizon.
Clay Tucker
Vice President, New Business Development — Western US
ConnectiveRx
B Access and Reimbursement Executive Exchange*
During this advanced session, benchmark with key industry directors and executives on challenges facing the industry amid shifting market dynamics. Driven by attendees, take time to collaborate with industry counterparts, ensure operational alignments and brainstorm strategic solutions to key initiatives that are impacting the future of access and reimbursement.
Chris Dowd
Executive Vice President,
Market and Product Development
ConnectiveRx
*CBI reserves the right to qualify participants for this session. Participants must be Director level or above and currently be employed by a life sciences manufacturer.
5:00
Close of Day One
COCKTAIL RECEPTION immediately following the final session Hosted by:
DAY TWO THURSDAY, APRIL 2, 2020
8:00
Breakfast Hosted by:
8:30
Chairperson’s Review of Day One
Chris Dowd
Executive Vice President, Market and Product Development
ConnectiveRx
Copay, Coupons and Accumulators
8:45
PATIENT SPOTLIGHT
An Inside Look at the Patient Experience and Real-World Access Challenges
Jenn McNary
Advocacy and Outreach Director
Beauhawks
9:30
Specialty Spotlight — Overcome Formulary, Coupon, Copay and Access Challenges
Ticia Cawley
Vice President, Specialty Programs
ConnectiveRx
Katrina Cooper, PharmD
Clinical Specialty Pharmacist
Vanderbilt Medical Center
10:30
Networking and Refreshment Break Hosted by:
11:00
Affordability First — Leverage Digital Engagements to Drive Affordability
Bob Raffo
President & CEO
FirstView
12:00
Networking Luncheon
1:15
CHOOSE FROM THREE TAILORED TRACKS (1-3)
TRACK 1 Access and Affordability
I. Look Beyond Free Drug Programs — Patient Support Models
II. Implement Performance Measurements to Justify the Cost of Copay Programs
TRACK LEADERS:
Brent Schwartz
Executive Director, Reimbursement – U.S. Eye Care
Allergan
Gerard Rivera, PharmD
CEO
Rx Experts (Subsidiary of Pacific Pharmacy Group)
TRACK 2 Rebates and Contracting
I. Explore Point-of-Sale Rebates and Discounts
II. Explore Innovative Pricing and Contracting Models —
Outcomes- Based Contracting, Long-Term Plans and Value-Based Pricing
TRACK LEADER:
Kim Gwiazdzinski
former Assistant Vice President Trade Relations, Value and Outcomes Contracting
Prime Therapeutics
TRACK 3 Strategic Launch Planning
I. Brand Strategy Guide for Pre-Commercialization Planning and Understand Market Access Impact to Propel Launch
II. Marketing in the 21st Century
TRACK LEADER:
Donna Situ
Executive Director
Portola Pharmaceuticals
3:30
Networking and Refreshment Break
4:00
Copay Accumulator Programs Intensive
As the adoption of copay accumulators and maximizers expand, so does the need for pharmaceutical manufacturers to ensure a comprehensive understanding of the impact to the commercially insured patient population. In this interactive intensive, unravel program complexities and navigate the impact of this cost-shifting benefit design.
Kevin O’Meara
Subject Matter Expert, Affordability & Accumulator Strategies
ConnectiveRx
5:00
Close of Day Two
Networking, Wine and Cheese Reception immediately following the final session on day two
DAY THREE FRIDAY, APRIL 23, 2020
8:00
Continental Breakfast
8:00
Chairman’s Review of Day Two
Chris Dowd
Executive Vice President, Market and Product Development
ConnectiveRx
Innovation and Digital Disruptions
8:45
Identify Disruptions in Market Access —
Major Market Mergers, Joint Ventures and Emerging Digital Innovators
Michael DiFiore
Head, Market Access
Sunovion Pharmaceuticals
9:30
Car-T/Cell and Gene Therapy Formulary Design —
How to Find Value and Pay for Curative Therapies
Lauren Sullivan
Member
Epstein Becker Green
10:15
Networking and Refreshment Break
10:45
TECH TALK
Leverage Digital Therapeutics and Mobile Health to Drive Efficiencies in the HealthCare Ecosystem
Andy Molnar
Senior Director, Market Access
Cognoa
12:00
Close of Conference
